Hongling Chu (Assistant Researcher)
Discipline: Clinical Research Methodology
Education: PhD
Affiliation: Peking University Third Hospital
Address: No. 49, North Huayuan Road, Haidian District, Beijing
Expert Profile：
Working at Peking University Third Hospital; Secretary of the International Society for Mixed Methods Research China society; Member of the Expert Committee on Pharmaceutical Economics and Comprehensive Evaluation of the Beijing Health Promotion Association; Member of the Beijing Society of Medical Ethics Rehabilitation Research Branch; Young Editorial Board Member of the Journal of Family Medicine and Community Health.
Research Interests
Clinical research design and implementation, process evaluation, implementation science, predictive modeling, qualitative research, mixed methods research
ORCID: 0000-0003-1846-9192
Research Projects：
1 National Natural Science Foundation of China, Major Project, 82090014, Role and Mechanism of Bioactive Small Molecules in Early Disease Evolution of Chronic Obstructive Lung, 2021-01-01 to 2025-12-31, $3,456,000, In progress, Participating
2 National Health and Medical Research Council of Australia, Clinical Trials and Cohort Fund, 1049417, Study of the relationship between low sodium salt and stroke (SSaSS), Start date: 2015.01-2020.12; $4.9 million, in progress, participation;
3 National Heart, Lung, and Blood Institute, HHSN268200900027C, China Rural Cardiovascular Disease High Risk Management and Salt Reduction Health Initiative (CRHI), start/end: 2010.01-2014.12, $5 million, completed, participation;
4 World Health Organization, 200120982, Early Identification and Health Education Interventions for Depression among Migrant Workers in Enterprises, approximately $1 million, start/end date: 2010.01-2012.12, completed, participant
5 Peking University Third Hospital, 2022 Teaching Research Project, 2022bysyjxkt, Design and Practice of Hybrid Teaching Model for Mixed Research Methods Course Based on Canvas Platform, 2022-01 to 2023-12, 20,000 Yuan, in progress, Chair
6 Evaluation of the implementation process of medical consortium response during the novel coronavirus pneumonia epidemic, 2020, Self-sponsored
Academic Achievements：
[1]Chu, Hongling; Zhang, Jing; Fetters, Michael D.; Niu, Wenyi; Li, Huijuan; Li, Nicole; Yan , Lijing L.; Wang, Yanfang; Wu, Yangfeng ; A Mixed Methods Process Evaluation of a Clustered-Rand omized Controlled Trial to Determine the Effects of Community-Based Dietary Sodium Reduction in R ural China, Frontiers in Medicine, 2021, 8(646576): 0-646576
[2]Liu Qiang#; Chu Hongling#; Michael P LaValley; David J Hunter; Zhang Hua; Tao Liyuan; Zhan Siyan; Lin Jianhao; Zhang Yuqing ; Prediction models for the risk of total knee replacement: deve lopment and validation using data from multicentre cohort studies, Lancet Rheumatology, 2022, 4(2 ): e125-e134
[3]Liu, Yishu; Chu, Hongling; Peng, Ke; Yin, Xuejun; Huang, Liping; Wu, Yangfeng; Pearson, S allie-Anne; Li, Nicole; Elliott, Paul; Yan, Lijing L.; Labarthe, Darwin R.; Hao, Zhixin; Feng, Xi angxian; Zhang, Jianxin; Zhang, Yuhong; Zhang, Ruijuan; Zhou, Bo; Li, Zhifang; Sun, Jixin; Zhao, Yi; Yu, Yan; Tian, Maoyi; Neal, Bruce; Liu, Hueiming ; Factors Associated With the Use of a Salt Substitute in Rural China, JAMA Network Open, 2021, 4(12): 0-e2137745
[4]Pan, Z#., Chu, H#., et al., Perspectives of research ethics committee members on human challenge studies in the development of vaccines against COVID-19: a mixed methods study. Ann Palliat Med, 2021. 10(6): p. 6259-6269.
[5]Liu, C#., Chu, H#., et al., The 20 most important questions for novices of full-endoscopic spinal surgery in China: a mixed-method study protocol. BMJ Open, 2021. 11(8): p. e049902.
[6] Ji, P#; Chu, H#., et al., How to strengthen clinical research in Shenzhen, China: a qualitative study. BMJ Open 2019.
[7] Chu Hongling; Park Yufan; She Ruifang; Zhen Dongyun; Li Han; Zeng Lin; Zhuo Lin; Tao Liyuan; Zhao Yiming; Lei Yi ; Response and implementation evaluation of a medical consortium in Beijing during a novel coronavirus pneumonia epidemic, Chinese Family Medicine, 2020, 23(31): 3905-3911
[8] Chu Hongling; Li Nan; Zeng Lin; Zhao Yiming; Zhan Siyan ; Guidelines for the application of qualitative research in randomized controlled trials, Beijing University Medical Press, 2019 (Academic Monograph)
[9] Chu, Hongling et al, Sample size determination for qualitative interviews based on information efficacy model. Chinese Family Medicine, 2021. 24(10): pp. 1274-1276+1283.
[10] Ji P, Chu H-L. Public and patient participation in medical research practice in the UK, Medicine and Philosophy, 2020. 41(20): pp. 78-81.
[11] Chu H-L, Zeng L, Zhao Y-M, Li F-W. Interpretation of guidelines for process evaluation of complex interventions. Chinese Journal of Evidence-Based Medicine, 2020, 20(11), 1353-1358.
[12] Chu H-L, Park Y-F, She R-F, Zhen D-Y, Li H, Zeng L, Zhuo L, Tao L-Y, Zhao Y-M, Lei Y. Response and implementation evaluation of a medical consortium in Beijing during a novel coronavirus pneumonia epidemic. Chinese Family Medicine, 2020. 23(31): pp. 3905-3911.
[13] Chu H-L, Li N & Zhao Y-M, The core of mixed methods research: integration. Chinese Journal of Pediatrics, 2020. 58(09): pp. 771-771
[14] Chu, H.L., Li, N., & Zeng, L., Translation. Zhan S-Y, Zhao Y-M. A Guide to Qualitative Research in Randomized Controlled Trials. Beijing University Medical Press, 2019. (Academic Monograph)
[15] Chu H-L et al, Introduction to process evaluation of complex intervention studies. Chinese Journal of Pediatrics, 2019(09): p. 659.